This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Organizing Committee

(image)

Douglas Chepeha | HEAD & NECK SURGERY

Professor
University of Toronto
Canada

Douglas B. Chepeha, MD, MSPH, FACS, FRCS(C) is a Professor in the Department of Otolaryngology at the University of Toronto.  He was Faculty at the University of Michigan for 19 years where he obtained the rank of full professor with tenure (now Adjunct Faculty) as well as directing the surgical oncology fellowship and co-director of the research committee and the tissue core.  While at the University of Michigan, he was part of a rich multidisciplinary environment that is directed toward solving questions though the conduct of innovative clinical trials relating to bioselection and individualized care. He helped pioneer efforts in sentinel node, selective neck dissection, microsurgical reconstruction and IMRT to improve swallowing outcomes.  In 2014 he returned to Canada as a Professor at the University of Toronto and a member of the Surgical Oncology Department at the Princess Margaret Hospital.  He is an Associate Member of the Institute of Medical Science at the University of Toronto and has mentored Master’s and Doctoral students in nutrition, speech and language pathology and engineering.  He has received grant support from the NIH, the AFP and University of Toronto. He teaches and lectures internationally.  Has a particular interest in teaching surgical dissection.  He is on the Head and Neck Surgical Subcommittee for the NRG and has served on committees in SWOG, ACOSOG, AAO-HNS, AHNS and COS-HNS.  He is the Co-Editor in Chief of the Journal of Otolaryngology-Head and Neck Surgery the official publication of the Canadian Society.  His research interests relate to clinical and translational questions in head and neck oncology. He has particular interest in clinical trials, neck dissection, tumor response, molecular epidemiology, and reconstructive surgery.  His clinical expertise is in the care of complex cancer patients with a focus on cutting edge technology to optimize their long term functional and survival outcomes.